20.90NOK-0.48%Mkt Cap: 926.80M NOKP/E: 12.44Last update: 2026-06-01
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; m…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap926.80M NOK
Enterprise Value925.41M NOK
Revenue (TTM)449.47M NOK
Gross Profit231.95M NOK
Net Income (TTM)74.75M NOK
Revenue/Share10.13 NOK
Last Price20.90 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees74
CountryNO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)12.44
P/E (Forward)—
PEG—
EV/EBITDA8.33
EV/Revenue2.06
P/S2.07
P/B2.83
EPS (TTM)1.68
EPS (Forward)—
52W Range
19.4021% of range26.40
52W High26.40 NOK
52W Low19.40 NOK
Profitability
Gross Margin51.28%
Oper. Margin19.18%
EBITDA Margin24.71%
Profit Margin16.53%
ROE22.73%
ROA17.01%
Growth
Revenue Growth-2.50%
Earnings Growth-1.20%
Cash Flow & Leverage
Operating CF78.04M NOK
CapEx (TTM)16.68M NOK
FCF Margin3.68%
FCF Yield1.78%
Net Debt-5.83M NOK
Net Debt/EBITDA-0.05
Balance Sheet
Debt/Equity0.00
Current Ratio2.96
Quick Ratio1.83
Book Value/Sh7.415 NOK
Cash/Share0.1430 NOK
Dividends
Fwd Div Rate2.250 NOK
Trail. Div Rate1.500 NOK
Div. Yield10.71%
5Y Avg Yield—
Payout Ratio74.40%
Ex-Div DateMay 22, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.44.34M
Float21.97M
Insiders58.94%
Institutions13.74%
Technical
SMA 5022.10 (-5.4%)
SMA 20021.78 (-4.1%)
Beta0.62
S&P 52W Chg27.70%
Avg Vol (30d)27.90K
Avg Vol (10d)12.10K
Technical Indicators
RSI (14)37.4
MACD-0.3036
MACD Signal-0.0924
MACD Hist.-0.2112
BB Upper23.48 NOK
BB Middle22.11 NOK
BB Lower20.73 NOK
BB Width12.41%
ATR (14)0.5741 NOK
Vol Ratio (20d)0.27x